DAB2 Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

DAB2 Polyklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), IP, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus, Ratte und mehr (1)

Anwendung

WB, IHC, IF/ICC, FC (Intra), IP, ELISA

Konjugation

Unkonjugiert

Publikationen(9)

Kat-Nr. : 10109-2-AP

Synonyme

Adaptor molecule disabled-2, Differentially expressed in ovarian carcinoma 2, Differentially-expressed protein 2, Disabled homolog 2, DOC 2

---

• 

  WB analysis using 10109-2-AP

  Hela cells were subjected to SDS PAGE followed by western blot with 10109-2-AP (DAB2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 10109-2-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 10109-2-AP (DAB2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of MCF-7 using 10109-2-AP

  MCF7 cells were subjected to SDS PAGE followed by western blot with 10109-2-AP (DAB2 antibody) at dilution of 1:16000 incubated at room temperature for 1.5 hours.

• 

  IP experiment of HeLa using 10109-2-AP

  IP result of anti-DAB2 (IP:10109-2-AP, 4ug; Detection:10109-2-AP 1:2000) with HeLa cells lysate 4000ug.

• 

  IHC staining of human kidney using 10109-2-AP

  Immunohistochemical analysis of paraffin-embedded human kidney tissue slide using 10109-2-AP (DAB2 Antibody) at dilution of 1:200 (under 10x lens).

• 

  IHC staining of human kidney using 10109-2-AP

  Immunohistochemical analysis of paraffin-embedded human kidney tissue slide using 10109-2-AP (DAB2 Antibody) at dilution of 1:200 (under 40x lens).

• 

  IF Staining of HeLa using 10109-2-AP

  Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using DAB2 antibody (10109-2-AP) at dilution of 1:200 and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L), CL594-phalloidin (red).

• 

  IF Staining of HeLa using 10109-2-AP

  Immunofluorescent analysis of (-20°C Ethanol) fixed HeLa cells using 10109-2-AP (DAB2 antibody) at dilution of 1:50 and Alexa Fluor 488-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L).

• 

  FC experiment of HeLa using 10109-2-AP

  1x10^6 HeLa cells were intracellularly stained with 0.25 ug DAB2 Polyclonal antibody (10109-2-AP) and CoraLite®488-Conjugated Goat Anti-Rabbit IgG(H+L) (SA00013-2)(red), or 0.25 ug rabbit IgG isotype control (blue). Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: HeLa-Zellen, MCF-7-Zellen, Rattenhodengewebe, RAW 264.7-Zellen
• Erfolgreiche IP: HeLa-Zellen
• Erfolgreiche Detektion in IHC: humanes Nierengewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
• Erfolgreiche Detektion in IF/ICC: HeLa-Zellen
• Erfolgreiche Detektion in FC (Intra): HeLa-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:500-1:2000
• Immunpräzipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunhistochemie (IHC): IHC : 1:50-1:500
• Immunfluoreszenz (IF)/ICC: IF/ICC : 1:50-1:500
• Durchflusszytometrie (FC) (INTRA): FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• KD/KO: See 1 publications below
• WB: See 4 publications below
• IHC: See 4 publications below
• IF: See 3 publications below
• IP: See 1 publications below

Produktinformation

10109-2-AP bindet in WB, IHC, IF/ICC, FC (Intra), IP, ELISA DAB2 und zeigt Reaktivität mit human, Maus, Ratten

• Getestete Reaktivität: human, Maus, Ratte
• In Publikationen genannte Reaktivität: human, Huhn
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: DAB2 fusion protein Ag0162
• Vollständiger Name: disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)
• Berechnetes Molekulargewicht: 82 kDa
• Beobachtetes Molekulargewicht: 96 kDa
• GenBank-Zugangsnummer: BC003064
• Gene symbol: DAB2
• Gene ID (NCBI): 1601
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS with 0.02% sodium azide and 50% glycerol
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

DAB2 is a protein of 770 amino acid residues with a predicted molecular weight of 85.5kDa. This gene was initially named DOC2 (for Differentially expressed in Ovarian Cancer) and is distinct from the DOC2A and DOC2B genes (for double C2-like domains, alpha and beta). Human DAB2 has an overall 83% identify with the mouse p96 protein, a putative mitogen-responsive phosphoprotein; homology is strongest in the amino-terminal end of the protein in a region corresponding to the phosphotyrosine interaction domain (PID), and contains multiple SH3 binding motifs. Chromosomal localization by FISH showed that the DAB2 gene is located on 5p13. The expression of DAB2 is down-regulated or absent in all the carcinoma cell lines examined, including prostate and ovarian carcinoma cell lines. The N-terminal domain of DAB2 interacts with Dishevelled-3 (Dvl-3), a signaling mediator of the Wnt pathway. Ectopic expression of DAB2 attenuates canonical Wnt/catenin-mediated signaling, including accumulation of catenin and cyclin D1 induction. DAB2 suppresses both protein kinase C and peptide growth factor-elicited signal pathways via the Ras-mitogen-activated protein kinase pathway. The proline-rich domain of DAB2 also interacts with proteins containing SH3 domain, such as Src and Fgr. The binding of DAB2 to c-Src resultes in the inactivation of c-Src. All data suggest that DAB2 is a potent tumor suppressor in many cancer types.

Publikationen

Species	Application	Title
human	IHC,IF	Theranostics; DAB2 + macrophages support FAP + fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer; Authors - Fei Long
Chicken	IP	Proc Natl Acad Sci U S A; FGFR1-mediated protocadherin-15 loading mediates cargo specificity during intraflagellar transport in inner ear hair-cell kinocilia.; Authors - Akira Honda
human	WB	Cancer Lett; MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.; Authors - Ya Fei Xu
human	IF	J Cell Physiol; Proper E-cadherin membrane location in colon requires Dab2 and it modifies by inflammation and cancer.; Authors - María D Vazquez-Carretero
human	IHC	Histopathology; Expression and clinical significance of the transforming growth factor-β signalling pathway in endometrial cancer.; Authors - Mhawech-Fauceglia Paulette P
human	IHC	Immunotargets Ther; Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis; Authors - Qiao Tang

{{ptg:RelatedPrimaryAntibodies}}